Boston Heart Diagnostics (Formerly Known As Boston Heart Lab)

22 articles about Boston Heart Diagnostics (Formerly Known As Boston Heart Lab)

• Boston Heart Diagnostics Launches LipoMap™: One of the Most Comprehensive Assessments of Lipid Metabolism Available

  10/3/2022

  Boston Heart Diagnostics is pleased to announce the availability of LipoMap™.

• Boston Heart Diagnostics Launches Polygenic Risk Scores Empowering the Next Generation of Clinical Genomics

  9/12/2022

  Boston Heart Diagnostics is pleased to announce the availability of the Polygenic Risk Map™. 

• Boston Heart Diagnostics Launches LipidSeq™-- An NGS Test for Common Genetic Disorders of Lipid Metabolism

  8/17/2022

  Boston Heart Diagnostics, part of the Eurofins network of companies, announces the launch of LipidSeq™, a revolutionary genetic test for cardiovascular disease.

• Boston Heart Diagnostics Launches Industry-Leading Small-Volume Product Line with over 40 Dried Blood Spot Tests

  8/3/2022

  Boston Heart Diagnostics Corporation, a clinical laboratory within the Eurofins network of companies, announced its launch of a broad range of tests with a dried blood spot collection.

• 

  Biopharma Update on the Novel Coronavirus: April 16

  4/16/2020

  Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 16, 2020.

• Eurofins' U.S. Clinical Diagnostics Network Launches Coronavirus (COVID-19) Antibody Testing

  4/3/2020

  The Eurofins' U.S. Clinical Diagnostics network announced that blood-based antibody testing for Coronavirus SARS-CoV-2 will begin Monday, April 6 at Boston Heart Diagnostics, a Eurofins subsidiary.

• Boston Heart Diagnostics Publishes Randomized Trial

  3/18/2019

  Boston Heart Diagnostics announced the publication of a new research study: “Cardiovascular Risk Factor Reduction in First Responders Resulting from and Individualized Lifestyle and Blood Test Program: A Randomized Controlled Trial”.

• Boston Heart Diagnostics Announces New Scientific Advisory Board Appointments

  9/18/2018

  Boston Heart Diagnostics’ 2018 Scientific Advisory Board is comprised of recognized experts in their respective medical fields.

• Pat Noland Appointed President Of Boston Heart Diagnostics

  5/25/2017

• Despite Theranos's Drama, Boston Heart Diagnostics Makes Genetic Testing in Your Own Kitchen a Reality

  11/24/2015

• Boston Heart Diagnostics Introduces StatinSmart

  11/19/2015

• Boston Heart Diagnostics Reaches Milestone In Statin Intolerance Testing

  9/8/2015

• Boston Heart Diagnostics’s Diagnostic Report Recognized By CIO Magazine As A CIO 100 Award Winner

  6/2/2015

• Boston Heart Diagnostics Continues Hiring While Expanding Framingham Headquarters

  3/27/2015

• Boston Heart Diagnostics (Formerly Known As Boston Heart Lab) Sold To Eurofins For $140 Million

  12/11/2014

• Boston Heart Diagnostics (Formerly Known As Boston Heart Lab) Granted New York Laboratory Permit For Diagnostic Testing

  4/15/2014

• Boston Heart Diagnostics (Formerly Known As Boston Heart Lab) Enables Healthcare Providers To Better Identify Near-Term Risk Of Heart Attack Or Stroke With Launch Of An Important Inflammation Marker, Myeloperoxidase (MPO)

  3/6/2014

• Boston Heart Diagnostics (Formerly Known As Boston Heart Lab) Awarded $1.0 Million In Tax Incentives From The Massachusetts Life Sciences Center

  2/21/2014

• Boston Heart Lab Changes Name to Boston Heart Diagnostics

  5/24/2011

• Susan Hertzberg Named CEO of Boston Heart Lab; Company Closes $10 Million in Series C Financing with Bain Capital Ventures as Lead Investor

  9/21/2010